BlackRock, Inc. 13D and 13G filings for Standard BioTools Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Standard BioTools Inc. LAB |
BLACKROCK INC BLK |
22,452,115 6.000% |
0 (Unchanged) |
Filing |
| 2024-10-24 2:02 pm Purchase |
2024-09-30 | 13G | Standard BioTools Inc. LAB |
BLACKROCK INC BLK |
22,452,115 6.000% |
20,434,905 (+1013.03%) |
Filing |
| 2022-07-08 4:57 pm Sale |
2022-06-30 | 13G | Standard BioTools Inc. LAB |
BLACKROCK INC BLK |
2,017,210 2.600% |
-4,234,020 (-67.73%) |
Filing |
| 2022-02-02 7:11 pm Purchase |
2021-12-31 | 13G | Standard BioTools Inc. LAB |
BLACKROCK INC BLK |
6,251,230 8.200% |
673,271 (+12.07%) |
Filing |
| 2021-01-29 09:56 am Purchase |
2020-12-31 | 13G | Standard BioTools Inc. LAB |
BLACKROCK INC BLK |
5,577,959 7.500% |
287,638 (+5.44%) |
Filing |